FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890210811> ?p ?o ?g. }

• W2890210811 abstract "Abstract There is a controversy in literature as to whether c-Abl is crucial for the induction of TAp63-mediated apoptosis and whether that inhibition of c-Abl with imatinib, which was designed to inhibit the oncogenic kinase BCR-ABL and c-kit, protects oocytes from chemotherapy-induced apoptosis in mice. No human data are available on this issue. We therefore aimed to explore whether genomic damage induced by chemotherapy drug cisplatin activates c-Abl along with TAp63 and the inhibition of c-Abl with imatinib prevents cisplatin-induced oocyte death and follicle loss in human ovary. Exposure to cisplatin induced DNA damage, activated TAp63 and SAPK/JNK pathway, and triggered apoptosis in the oocytes and granulosa cells. However, TAp63 activation after cisplatin was not associated with any increase in the expression of c-Abl. Imatinib did not prevent cisplatin-induced apoptosis of the granulosa cells or oocytes. Moreover, treatment with this drug resulted in the formation of bizarre shaped follicles lacking oocytes and increased follicular atresia by inducing apoptosis of granulosa cells and oocytes. Similar toxic effects were observed when ovarian tissue samples were incubated with a c-kit antagonist drug anti-CD117, but not with another c-Abl tyrosine kinase inhibitor GNF-2, which lacks an inhibitory action on c-kit. Intraperitoneal administration of imatinib to the xenografted animals produced similar histomorphological abnormalities in the follicles in human ovarian grafts and did not prevent cisplatin-induced follicle loss when co-administered with cisplatin. Our findings provide, for the first time, a molecular evidence for ovarian toxicity of this drug in human. Furthermore, this study together with two previous case reports of a severely compromised ovarian response to gonadotropin stimulation and premature ovarian failure in patients, while receiving imatinib, further heighten the concerns about its potential gonadotoxicity on human ovary and urge caution in its use in young female patients." @default.
• W2890210811 created "2018-09-27" @default.
• W2890210811 creator A5015846521 @default.
• W2890210811 creator A5023619301 @default.
• W2890210811 creator A5038331863 @default.
• W2890210811 creator A5060565512 @default.
• W2890210811 creator A5076605015 @default.
• W2890210811 date "2018-09-20" @default.
• W2890210811 modified "2023-10-12" @default.
• W2890210811 title "C-Abl is not actıvated in DNA damage-induced and Tap63-mediated oocyte apoptosıs in human ovary" @default.
• W2890210811 cites W1968088508 @default.
• W2890210811 cites W1974017764 @default.
• W2890210811 cites W1996890993 @default.
• W2890210811 cites W2004758124 @default.
• W2890210811 cites W2008531519 @default.
• W2890210811 cites W2009930978 @default.
• W2890210811 cites W2013714082 @default.
• W2890210811 cites W2016576372 @default.
• W2890210811 cites W2016859429 @default.
• W2890210811 cites W2020391016 @default.
• W2890210811 cites W2028586759 @default.
• W2890210811 cites W2036724879 @default.
• W2890210811 cites W2037977021 @default.
• W2890210811 cites W2042272294 @default.
• W2890210811 cites W2042336905 @default.
• W2890210811 cites W2059222716 @default.
• W2890210811 cites W2062250663 @default.
• W2890210811 cites W2067955289 @default.
• W2890210811 cites W2068658654 @default.
• W2890210811 cites W2086638852 @default.
• W2890210811 cites W2088744498 @default.
• W2890210811 cites W2090004346 @default.
• W2890210811 cites W2114734999 @default.
• W2890210811 cites W2136159364 @default.
• W2890210811 cites W2138165502 @default.
• W2890210811 cites W2139777504 @default.
• W2890210811 cites W2159086967 @default.
• W2890210811 cites W2167555656 @default.
• W2890210811 cites W2178132864 @default.
• W2890210811 cites W2180681796 @default.
• W2890210811 cites W2203115432 @default.
• W2890210811 cites W2789800718 @default.
• W2890210811 cites W4255236038 @default.
• W2890210811 doi "https://doi.org/10.1038/s41419-018-1026-7" @default.
• W2890210811 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6148240" @default.
• W2890210811 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30237472" @default.
• W2890210811 hasPublicationYear "2018" @default.
• W2890210811 type Work @default.
• W2890210811 sameAs 2890210811 @default.
• W2890210811 citedByCount "27" @default.
• W2890210811 countsByYear W28902108112019 @default.
• W2890210811 countsByYear W28902108112020 @default.
• W2890210811 countsByYear W28902108112021 @default.
• W2890210811 countsByYear W28902108112022 @default.
• W2890210811 countsByYear W28902108112023 @default.
• W2890210811 crossrefType "journal-article" @default.
• W2890210811 hasAuthorship W2890210811A5015846521 @default.
• W2890210811 hasAuthorship W2890210811A5023619301 @default.
• W2890210811 hasAuthorship W2890210811A5038331863 @default.
• W2890210811 hasAuthorship W2890210811A5060565512 @default.
• W2890210811 hasAuthorship W2890210811A5076605015 @default.
• W2890210811 hasBestOaLocation W28902108111 @default.
• W2890210811 hasConcept C134018914 @default.
• W2890210811 hasConcept C190283241 @default.
• W2890210811 hasConcept C2776694085 @default.
• W2890210811 hasConcept C2777583451 @default.
• W2890210811 hasConcept C2778239845 @default.
• W2890210811 hasConcept C2778324911 @default.
• W2890210811 hasConcept C2778729363 @default.
• W2890210811 hasConcept C2780536345 @default.
• W2890210811 hasConcept C2780992837 @default.
• W2890210811 hasConcept C3019892230 @default.
• W2890210811 hasConcept C502942594 @default.
• W2890210811 hasConcept C54355233 @default.
• W2890210811 hasConcept C55493867 @default.
• W2890210811 hasConcept C86803240 @default.
• W2890210811 hasConcept C95444343 @default.
• W2890210811 hasConcept C98274493 @default.
• W2890210811 hasConceptScore W2890210811C134018914 @default.
• W2890210811 hasConceptScore W2890210811C190283241 @default.
• W2890210811 hasConceptScore W2890210811C2776694085 @default.
• W2890210811 hasConceptScore W2890210811C2777583451 @default.
• W2890210811 hasConceptScore W2890210811C2778239845 @default.
• W2890210811 hasConceptScore W2890210811C2778324911 @default.
• W2890210811 hasConceptScore W2890210811C2778729363 @default.
• W2890210811 hasConceptScore W2890210811C2780536345 @default.
• W2890210811 hasConceptScore W2890210811C2780992837 @default.
• W2890210811 hasConceptScore W2890210811C3019892230 @default.
• W2890210811 hasConceptScore W2890210811C502942594 @default.
• W2890210811 hasConceptScore W2890210811C54355233 @default.
• W2890210811 hasConceptScore W2890210811C55493867 @default.
• W2890210811 hasConceptScore W2890210811C86803240 @default.
• W2890210811 hasConceptScore W2890210811C95444343 @default.
• W2890210811 hasConceptScore W2890210811C98274493 @default.
• W2890210811 hasIssue "10" @default.
• W2890210811 hasLocation W28902108111 @default.
• W2890210811 hasLocation W28902108112 @default.
• W2890210811 hasLocation W28902108113 @default.
• W2890210811 hasLocation W28902108114 @default.
• W2890210811 hasLocation W28902108115 @default.

• next